Nature Podcast cover image

Coronapod: Why COVID antibody treatments may not be the answer

Nature Podcast

CHAPTER

Monoclonal Antibodies - Is There Resistance?

There are some people who are quite concerned that if you start rolling out individual monoclonal annabody therapie s on a wide scale tat you're going to encourage the development of resistance. So that is a concern. There was an interesting development in that case, i guess, with one of the antabodies that had clinical trial results announced last week. And that particular annaboty targets a bit of a protein that tends to not mutate, tends to stay very stable.

00:00
Transcript
Play full episode

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
App store bannerPlay store banner